DK0611397T3 - Vaccine mod katteleukæmivirus - Google Patents

Vaccine mod katteleukæmivirus

Info

Publication number
DK0611397T3
DK0611397T3 DK92922254T DK92922254T DK0611397T3 DK 0611397 T3 DK0611397 T3 DK 0611397T3 DK 92922254 T DK92922254 T DK 92922254T DK 92922254 T DK92922254 T DK 92922254T DK 0611397 T3 DK0611397 T3 DK 0611397T3
Authority
DK
Denmark
Prior art keywords
leukemia virus
vaccine against
against cat
cat leukemia
vaccine
Prior art date
Application number
DK92922254T
Other languages
Danish (da)
English (en)
Inventor
Richard Calvert Wardley
Darrell Ray Thomsen
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK0611397T3 publication Critical patent/DK0611397T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/14011Baculoviridae
    • C12N2710/14111Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/13011Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/13011Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK92922254T 1991-11-08 1992-10-08 Vaccine mod katteleukæmivirus DK0611397T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78916391A 1991-11-08 1991-11-08
US85706492A 1992-03-25 1992-03-25
PCT/US1992/008427 WO1993009238A1 (en) 1991-11-08 1992-10-08 Feline leukemia virus vaccines

Publications (1)

Publication Number Publication Date
DK0611397T3 true DK0611397T3 (da) 2002-10-07

Family

ID=27120881

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92922254T DK0611397T3 (da) 1991-11-08 1992-10-08 Vaccine mod katteleukæmivirus

Country Status (12)

Country Link
EP (2) EP0611397B1 (de)
JP (1) JP2852395B2 (de)
KR (1) KR100265393B1 (de)
AT (1) ATE219520T1 (de)
AU (2) AU672372B2 (de)
CA (1) CA2120137C (de)
DE (1) DE69232650T2 (de)
DK (1) DK0611397T3 (de)
ES (1) ES2177530T3 (de)
LV (1) LV13060B (de)
MX (1) MX9206018A (de)
WO (1) WO1993009238A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090379A (en) * 1992-04-29 2000-07-18 Boyce Thompson Institute For Plant Research, Inc. Stable pre-occluded virus particle for use in recombinant protein production and pesticides
US5593669A (en) * 1992-04-29 1997-01-14 Boyce Thompson Institute For Plant Research, Inc. Stable pre-occluded virus particle
ATE243259T1 (de) * 1992-04-29 2003-07-15 Thompson Boyce Plant Res Mundinfektion der insektlarven mit prä- okkludierten bakuloviruspartikeln
FR2715664B1 (fr) * 1994-01-31 1996-04-12 Proteine Performance Sa Baculovirus recombinant et son utilisation pour la production d'anticorps monoclonaux.
CA2158977A1 (en) 1994-05-09 1995-11-10 James G. Respess Retroviral vectors having a reduced recombination rate
US6013517A (en) * 1994-05-09 2000-01-11 Chiron Corporation Crossless retroviral vectors
US6248582B1 (en) * 1997-10-08 2001-06-19 Imran Khan Gene deleted recombinant FeLV proviral DNA for production of vaccines against FeLV
KR20190062084A (ko) 2017-11-28 2019-06-05 주식회사 제트바이오텍 고양이 백혈병 바이러스 검출용 프라이머 및 이를 포함한 진단 키트
CN109679970B (zh) * 2018-11-20 2020-12-08 杭州贤至生物科技有限公司 猫疱疹i型病毒快速检测的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0173997A1 (de) * 1984-09-06 1986-03-12 Chiron Corporation Katzenleukämievirusproteinimpfstoffe und ihre Herstellung
AU607399B2 (en) * 1985-09-09 1991-03-07 Cetus Corporation Infectious recombinant virus vaccine for feline leukemia
GR862412B (en) * 1985-09-25 1987-01-23 Oncogen Vaccines and immuinoassays for acquired immune deficiency syndrome
ZA867281B (en) * 1985-09-25 1987-05-27 Oncogen Vaccines and immunoassays for acquired immune deficiency syndrome
GB8523999D0 (en) * 1985-09-30 1985-11-06 Jabay Ltd Injection of liquid into meat
WO1987007301A1 (en) * 1986-05-30 1987-12-03 Cambridge Bioscience Corporation Method of preparation and use for feline leukemia virus antigens
EP0427788B1 (de) * 1988-08-08 1995-11-22 The Upjohn Company Verfahren zur isolierung für thymidin-kinase der herpesvirus kodierenden dns
ES2052478T1 (es) * 1989-11-20 1994-07-16 Oncogen Particulas retrovirales no replicantes producidas de forma recombinante empleadas como agentes antivirales e inmunogenos.

Also Published As

Publication number Publication date
DE69232650T2 (de) 2002-11-28
WO1993009238A1 (en) 1993-05-13
KR100265393B1 (ko) 2000-10-02
EP0611397B1 (de) 2002-06-19
EP1136562A3 (de) 2003-06-25
ATE219520T1 (de) 2002-07-15
AU4213496A (en) 1996-04-26
AU672372B2 (en) 1996-10-03
CA2120137A1 (en) 1993-05-13
JP2852395B2 (ja) 1999-02-03
JPH06510910A (ja) 1994-12-08
CA2120137C (en) 2004-05-04
AU2892392A (en) 1993-06-07
EP0611397A1 (de) 1994-08-24
DE69232650D1 (de) 2002-07-25
LV13060B (en) 2003-12-20
AU689355B2 (en) 1998-03-26
ES2177530T3 (es) 2002-12-16
MX9206018A (es) 1993-05-01
EP1136562A2 (de) 2001-09-26

Similar Documents

Publication Publication Date Title
FI923443A0 (fi) Foereningar och foerfarande foer inhibering av hiv och liknande virus.
CY2007016I2 (el) Εμβολιο ιου θηλωματος
DE68929467D1 (de) HIV-2 Varianten
TR26855A (tr) Dis-tasina karsi agiz bilesimleri.
NO890299L (no) Bifunksjonelt vekstmodulerende glycoprotein benevnt amiphiregulin.
IT8821913V0 (it) Maschera per immersione.
DK0611397T3 (da) Vaccine mod katteleukæmivirus
FI891449A (fi) Nya 2,3,4-substituerade imidazoler och 3,4,5-substituerade 1,2,4-triazoler, deras framstaellning och anvaendning.
FI921974A0 (fi) Lageranlaeggning och undervattens- drivkraftsenhet som innehaoller den.
DE68910577D1 (de) Mittel gegen den AIDS-Virus.
DE68918359D1 (de) Handabtastdrucker.
FI894798A0 (fi) Nya 1,4-bensoxazin- och 1,4-bensotiazinderivat och foerfarande foer deras framstaellning.
FI894009A0 (fi) Integrerad minneskrets innehaollande en parallell och serieformig ingaong och utgaong.
ES2104752T3 (es) Materiales dentales a base de (met)acrilatos.
FI890285A0 (fi) Nya aminosyraglycerider, foerfaranden foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning.
FI922954A0 (fi) Nya glykopeptider, foerfarande foer deras framstaellning och deras anvaendning.
KR950700933A (ko) 사람 면역결핍 바이러스(HIV) 표면 당단백질로부터 유래된 합성 폴리펩타이드(Synthetic polypeptides derived from the HIV envelope glycoprotein)
FI934777A (fi) Multipel hepatitis b virus ytproteiner som bildar partiklar
DE68908195D1 (de) Porphyrie erzeugende insektizide.
DE59204210D1 (de) Zahnärztliches handstück.
MX9206973A (es) Vacuna a base de virus del herpes bovino modificado tipo 1.
ES2083428T3 (es) Uso de derivados de isoxazolin-3-ona como antidepresivos.
FI890380A0 (fi) Nya kondenserande diazepinoner, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel.
NO901959L (no) Malaria-vaksine.
FI894268A0 (fi) Kolvkonstruktion och foerfarande foer att montera den.